SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    E. Sagnelli, T. Santantonio, N. Coppola, M. Fasano, M. Pisaturo, C. Sagnelli, Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment, Infection, 2014,

    CrossRef

  2. 2
    Suraj A. Sharma, Jordan J. Feld, Acute Hepatitis C: Management in the Rapidly Evolving World of HCV, Current Gastroenterology Reports, 2014, 16, 2

    CrossRef

  3. 3
    Tzu-Hao Lee, Hans L. Tillmann, Keyur Patel, Individualized Therapy for Hepatitis C Infection: Focus on the Interleukin-28B Polymorphism in Directing Therapy, Molecular Diagnosis & Therapy, 2014, 18, 1, 25

    CrossRef

  4. 4
    Ivan Gentile, Antonio Riccardo Buonomo, Federico Borgia, Emanuela Zappulo, Giuseppe Castaldo, Guglielmo Borgia, MK-5172: a second-generation protease inhibitor for the treatment of hepatitis C virus infection, Expert Opinion on Investigational Drugs, 2014, 23, 5, 719

    CrossRef

  5. 5
    Clémence Arnaud, Christian Trépo, Marie-Anne Petit, Predictors of the therapeutic response in hepatitis C. A 2013 update, Clinics and Research in Hepatology and Gastroenterology, 2014, 38, 1, 12

    CrossRef

  6. 6
    Kentaro Matsuura, Tsunamasa Watanabe, Yasuhito Tanaka, Role of IL28B for chronic hepatitis C treatment toward personalized medicine, Journal of Gastroenterology and Hepatology, 2014, 29, 2
  7. 7
    Ho Kil, Sook-Hyang Jeong, Jin-Wook Kim, Young Sang Byoun, Bo Young Min, Byung-Hyun Woo, Youn Jae Lee, Young Seok Kim, Role of Interleukin-28B Genetic Polymorphisms in Korean Patients with Hepatitis C Virus Infection, Gut and Liver, 2014, 8, 1, 70

    CrossRef

  8. 8
    Jason Grebely, Kimberly Page, Rachel Sacks-Davis, Maarten Schim Loeff, Thomas M. Rice, Julie Bruneau, Meghan D. Morris, Behzad Hajarizadeh, Janaki Amin, Andrea L. Cox, Arthur Y. Kim, Barbara H. McGovern, Janke Schinkel, Jacob George, Naglaa H. Shoukry, Georg M. Lauer, Lisa Maher, Andrew R. Lloyd, Margaret Hellard, Gregory J. Dore, Maria Prins, The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection, Hepatology, 2014, 59, 1
  9. 9
    Sandra Beinhardt, Berit Anna Payer, Christian Datz, Michael Strasser, Andreas Maieron, Livia Dorn, Evelyn Grilnberger-Franz, Emina Dulic-Lakovic, Rudolf Stauber, Hermann Laferl, Judith H. Aberle, Heidemarie Holzmann, Christoph Krall, Wolfgang Vogel, Peter Ferenci, Harald Hofer, A diagnostic score for the prediction of spontaneous resolution of acute hepatitis C virus infection, Journal of Hepatology, 2013, 59, 5, 972

    CrossRef

  10. 10
    Amanda Fernández-Rodríguez, Norma Rallón, Juan Berenguer, María A. Jiménez-Sousa, Jaime Cosín, María Guzmán-Fulgencio, Clara Restrepo, Juan C. Lopez, Mónica García-Álvarez, Pilar Miralles, Vicente Soriano, Jose M. Benito, Salvador Resino, Analysis of IL28B alleles with virologic response patterns and plasma cytokine levels in HIV/HCV-coinfected patients, AIDS, 2013, 27, 2, 163

    CrossRef

  11. 11
    Stephanie Jost, Marcus Altfeld, Control of Human Viral Infections by Natural Killer Cells, Annual Review of Immunology, 2013, 31, 1, 163

    CrossRef

  12. 12
    Katja Deterding, Norbert Grüner, Peter Buggisch, Johannes Wiegand, Peter R Galle, Ulrich Spengler, Holger Hinrichsen, Thomas Berg, Andrej Potthoff, Nisar Malek, Anika Großhennig, Armin Koch, Helmut Diepolder, Stefan Lüth, Sandra Feyerabend, Maria Christina Jung, Magdalena Rogalska-Taranta, Verena Schlaphoff, Markus Cornberg, Michael P Manns, Heiner Wedemeyer, Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial, The Lancet Infectious Diseases, 2013, 13, 6, 497

    CrossRef

  13. 13
    Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore, Epidemiology and natural history of HCV infection, Nature Reviews Gastroenterology & Hepatology, 2013, 10, 9, 553

    CrossRef

  14. You have free access to this content14
    Y. Maor, G. Morali, D. Bashari, G. Pénaranda, J. M. Schapiro, U. Martinowitz, P. Halfon, Genetic polymorphism of IL28B in hepatitis C-infected haemophilia patients in Israel, Haemophilia, 2013, 19, 1
  15. 15
    T. Watanabe, F. Sugauchi, Y. Tanaka, K. Matsuura, H. Yatsuhashi, S. Murakami, S. Iijima, E. Iio, M. Sugiyama, T. Shimada, M. Kakuni, M. Kohara, M. Mizokami, Hepatitis C virus kinetics by administration of pegylated interferon-  in human and chimeric mice carrying human hepatocytes with variants of the IL28B gene, Gut, 2013, 62, 9, 1340

    CrossRef

  16. 16
    Wan-Long Chuang, Ming-Lung Yu, Host factors determining the efficacy of hepatitis C treatment, Journal of Gastroenterology, 2013, 48, 1, 22

    CrossRef

  17. 17
    Chen-Hua Liu, Jia-Horng Kao, IL28B Genotype on HCV Infection in Asia, Current Hepatitis Reports, 2013, 12, 3, 149

    CrossRef

  18. 18
    P. N. Morcos, S. A. Moreira, B. J. Brennan, S. Blotner, N. S. Shulman, P. F. Smith, Influence of chronic hepatitis C infection on cytochrome P450 3a4 activity using midazolam as an in vivo probe substrate, European Journal of Clinical Pharmacology, 2013, 69, 10, 1777

    CrossRef

  19. 19
    Ming-Hua Zheng, Yu Li, Dong-Dong Xiao, Ke-Qing Shi, Yu-Chen Fan, Li-Li Chen, Wen-Yue Liu, Ying-Wan Luo, Yong-Ping Chen, Interleukin-28B rs12979860C/T and rs8099917T/G contribute to spontaneous clearance of hepatitis C virus in Caucasians, Gene, 2013, 518, 2, 479

    CrossRef

  20. 20
    Yu Liu, Hongli Ma, Shanhua Chen, Jingxing Wang, Gui Liu, Min Xu, Ling Ke, Miao He, Interleukin-28B genetic variations and spontaneous clearance of hepatitis C antibody–positive blood donors in China, Transfusion, 2013, 53, 10pt2
  21. 21
    Jacqueline K Flynn, Gregory J Dore, Margaret Hellard, Barbara Yeung, William D Rawlinson, Peter A White, John M Kaldor, Andrew R Lloyd, Rosemary A Ffrench, Maintenance of Th1 hepatitis C virus (HCV)-specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment, Journal of Gastroenterology and Hepatology, 2013, 28, 11
  22. 22
    Adriaan J. Meer, Raoel Maan, Robert J. Knegt, Bart J. Veldt, Natural History of HCV-induced Liver Disease, Current Hepatitis Reports, 2013, 12, 4, 251

    CrossRef

  23. 23
    Jason Grebely, Jordan J. Feld, Tanya Applegate, Gail V. Matthews, Margaret Hellard, Alana Sherker, Kathy Petoumenos, Geng Zang, Ineke Shaw, Barbara Yeung, Jacob George, Suzy Teutsch, John M. Kaldor, Vera Cherepanov, Julie Bruneau, Naglaa H. Shoukry, Andrew R. Lloyd, Gregory J. Dore, Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection, Hepatology, 2013, 57, 6
  24. 24
    Simona Bota, Ioan Sporea, Roxana Şirli, Adriana Maria Neghină, Alina Popescu, Mihnea Străin, Role of Interleukin-28B Polymorphism as a Predictor of Sustained Virological Response in Patients with Chronic Hepatitis C Treated with Triple Therapy: A Systematic Review and Meta-Analysis, Clinical Drug Investigation, 2013, 33, 5, 325

    CrossRef

  25. 25
    Clara Sánchez, Zulema Plaza, Eugenia Vispo, Carmen Mendoza, Pablo Barreiro, José V. Fernández-Montero, Pablo Labarga, Eva Poveda, Vincent Soriano, Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain, Liver International, 2013, 33, 9
  26. 26
    Golo Ahlenstiel, The Natural Killer Cell Response to HCV Infection, Immune Network, 2013, 13, 5, 168

    CrossRef

  27. 27
    Alessandra Mangia, Rosanna Santoro, Massimiliano Copetti, Marco Massari, Valeria Piazzolla, Enea Spada, Giuseppe Cappucci, Gabriele Missale, Leonardo Mottola, Ernesto Agostinacchio, Lazzaro di Mauro, Ornella Zuccaro, Patrizia Maio, Fabio Pellegrini, Antonella Folgori, Carlo Ferrari, Treatment optimization and prediction of HCV clearance in patients with acute HCV infection, Journal of Hepatology, 2013, 59, 2, 221

    CrossRef

  28. 28
    Hans L. Tillmann, Acute HCV: Will IL28B Testing Change the Paradigm?, Current Hepatitis Reports, 2012, 11, 1, 10

    CrossRef

  29. 29
    Joseph S. Doyle, Rachel Sacks-Davis, Margaret E. Hellard, Acute Hepatitis C Infection: New Approaches to Surveillance, Treatment and Prevention, Current Hepatitis Reports, 2012, 11, 4, 221

    CrossRef

  30. 30
    Heshaam M. Mir, Maria Stepanova, Mariam Afendy, Marcelo Kugelmas, Zobair M. Younossi, African Americans Are Less Likely to Have Clearance of Hepatitis C Virus Infection, Journal of Clinical Gastroenterology, 2012, 46, 8, e62

    CrossRef

  31. 31
    Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore, Case definitions for acute hepatitis C virus infection: A systematic review, Journal of Hepatology, 2012, 57, 6, 1349

    CrossRef

  32. 32
    Janett Fischer, Stephan Böhm, Markus Scholz, Tobias Müller, Heiko Witt, Jacob George, Christoph Sarrazin, Simone Susser, Eckart Schott, Vijayaprakash Suppiah, David R. Booth, Graeme J. Stewart, Florian van Bömmel, Annika Brodzinski, Balazs Fülöp, Pascal Migaud, Thomas Berg, Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection, Hepatology, 2012, 55, 6
  33. 33
    Heidar Sharafi, Ali Pouryasin, Seyed Moayed Alavian, Bita Behnava, Maryam Keshvari, Leila Mehrnoush, Shima Salimi, Osveh Kheradvar, Development and Validation of a Simple, Rapid and Inexpensive PCR-RFLP Method for Genotyping of Common IL28B Polymorphisms: A Useful Pharmacogenetic Tool for Prediction of Hepatitis C Treatment Response, Hepatitis Monthly, 2012, 12, 3, 190

    CrossRef

  34. 34
    Christoph Boesecke, Heiner Wedemeyer, Jürgen Kurt Rockstroh, Diagnosis and Treatment of Acute Hepatitis C Virus Infection, Infectious Disease Clinics of North America, 2012, 26, 4, 995

    CrossRef

  35. 35
    J. A. Holmes, P. V. Desmond, A. J. Thompson, Does IL28B genotyping still have a role in the era of direct-acting antiviral therapy for chronic hepatitis C infection?, Journal of Viral Hepatitis, 2012, 19, 10
  36. 36
    Alexander J. Thompson, Genetic Factors and Hepatitis C Virus Infection, Gastroenterology, 2012, 142, 6, 1335

    CrossRef

  37. 37
    C. Nelson Hayes, Michio Imamura, Hiroshi Aikata, Kazuaki Chayama, Genetics of IL28B and HCV—response to infection and treatment, Nature Reviews Gastroenterology & Hepatology, 2012, 9, 7, 406

    CrossRef

  38. 38
    Ching-Sheng Hsu, Jia-Horng Kao, Genomic variation-guided management in chronic hepatitis C, Expert Review of Gastroenterology & Hepatology, 2012, 6, 4, 497

    CrossRef

  39. 39
    Lorenzo Uccellini, Fan-Chen Tseng, Alessandro Monaco, Fatma M. Shebl, Ruth Pfeiffer, Myhanh Dotrang, Dianna Buckett, Michael P. Busch, Ena Wang, Brian R. Edlin, Francesco M. Marincola, Thomas R. O'Brien, HCV RNA levels in a multiethnic cohort of injection drug users: Human genetic, viral and demographic associations, Hepatology, 2012, 56, 1
  40. 40
    F. Pons Renedo, J. de la Revilla Negro, J.L. Calleja Panero, Hepatitis aguda por virus C: diagnóstico y tratamiento, Medicine - Programa de Formación Médica Continuada Acreditado, 2012, 11, 9, 565

    CrossRef

  41. 41
    Jason Grebely, Maria Prins, Margaret Hellard, Andrea L Cox, William O Osburn, Georg Lauer, Kimberly Page, Andrew R Lloyd, Gregory J Dore, Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine, The Lancet Infectious Diseases, 2012, 12, 5, 408

    CrossRef

  42. 42
    Swastik Agrawal, Radha K.. Dhiman, Hepatobiliary Quiz-3 (2012), Journal of Clinical and Experimental Hepatology, 2012, 2, 3, 297

    CrossRef

  43. 43
    Paul J Clark, Alexander J Thompson, Host genomics and HCV treatment response, Journal of Gastroenterology and Hepatology, 2012, 27, 2
  44. 44
    H.-Y. Rao, D.-G. Sun, D. Jiang, R.-F. Yang, F. Guo, J.-H. Wang, F. Liu, H.-Y. Zhang, H.-H. Zhang, S.-C. Du, Q. Jin, H. Qin, A.-S.-F. Lok, L. Wei, IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection, Journal of Viral Hepatitis, 2012, 19, 3
  45. 45
    Christoph T. Berger, Arthur Y. Kim, IL28B Polymorphisms as a Pretreatment Predictor of Response to HCV Treatment, Infectious Disease Clinics of North America, 2012, 26, 4, 863

    CrossRef

  46. 46
    Sylvie Deuffic-Burban, Hélène Castel, Johannes Wiegand, Michael P. Manns, Heiner Wedemeyer, Philippe Mathurin, Yazdan Yazdanpanah, Immediate vs. delayed treatment in patients with acute hepatitis C based on IL28B polymorphism: A model-based analysis, Journal of Hepatology, 2012, 57, 2, 260

    CrossRef

  47. 47
    Micaela B. Reddy, Yuan Chen, Joshua Ö. Haznedar, Jennifer Fretland, Steven Blotner, Patrick Smith, Jonathan Q. Tran, Impact of Low-Dose Ritonavir on Danoprevir Pharmacokinetics, Clinical Pharmacokinetics, 2012, 51, 7, 457

    CrossRef

  48. 48
    J. K. Flynn, G. J. Dore, G. Matthews, M. Hellard, B. Yeung, W. D. Rawlinson, P. A. White, J. M. Kaldor, A. R. Lloyd, R. A. Ffrench, Impaired Hepatitis C Virus (HCV)-Specific Interferon-  Responses in Individuals With HIV Who Acquire HCV Infection: Correlation With CD4+ T-Cell Counts, Journal of Infectious Diseases, 2012, 206, 10, 1568

    CrossRef

  49. 49
    Ke-Qing Shi, Wen-Yue Liu, Xian-Feng Lin, Yu-Chen Fan, Yong-Ping Chen, Ming-Hua Zheng, Interleukin-28B polymorphisms on the SVR in the treatment of naïve chronic hepatitis C with pegylated interferon-α plus ribavirin: A meta-analysis, Gene, 2012, 507, 1, 27

    CrossRef

  50. 50
    Sandra Beinhardt, Judith H. Aberle, Michael Strasser, Emina Dulic–Lakovic, Andreas Maieron, Anna Kreil, Karoline Rutter, Albert F. Staettermayer, Christian Datz, Thomas M. Scherzer, Robert Strassl, Martin Bischof, Rudolf Stauber, Gerd Bodlaj, Hermann Laferl, Heidemarie Holzmann, Petra Steindl–Munda, Peter Ferenci, Harald Hofer, Serum Level of IP-10 Increases Predictive Value of IL28B Polymorphisms for Spontaneous Clearance of Acute HCV Infection, Gastroenterology, 2012, 142, 1, 78

    CrossRef

  51. 51
    Karla J Helbig, Michael R Beard, The interferon signaling pathway genes as biomarkers of hepatitis C virus disease progression and response to treatment, Biomarkers in Medicine, 2012, 6, 2, 141

    CrossRef

  52. 52
    Joseph S. Doyle, Margaret E. Hellard, Alexander J. Thompson, The role of viral and host genetics in natural history and treatment of chronic HCV infection, Best Practice & Research Clinical Gastroenterology, 2012, 26, 4, 413

    CrossRef

  53. 53
    Jordan J. Feld, Treatment indication and response to standard of care with peginterferon and ribavirin in acute and chronic HCV infection, Best Practice & Research Clinical Gastroenterology, 2012, 26, 4, 429

    CrossRef

  54. 54
    Hideyuki Iwashita, Satoshi Shakado, Shinya Nishizawa, Shizuka Kuno, Teruo Matsumoto, Hideo Kunimoto, Kaoru Yotsumoto, Atsushi Fukunaga, Kunitoshi Sakurai, Genryu Hirano, Syuichi Ueda, Keiji Yokoyama, Daisuke Morihara, Masaharu Sakamoto, Akira Anan, Yasuaki Takeyama, Makoto Irie, Kaoru Iwata, Kazuhiro Ohta, Tetsuro Sohda, Kazuaki Inoue, Shinsyo Yoshiba, Shotaro Sakisaka, Two cases of acute hepatitis type C that improved with multidisciplinary therapy and interferon, Kanzo, 2012, 53, 2, 101

    CrossRef

  55. 55
    Jason Grebely, Margaret Hellard, Tanya Applegate, Kathy Petoumenos, Barbara Yeung, Jordan J. Feld, William Rawlinson, Andrew R. Lloyd, Jacob George, John M. Kaldor, Gregory J. Dore, Gail V. Matthews, Virological responses during treatment for recent hepatitis C virus, AIDS, 2012, 26, 13, 1653

    CrossRef

  56. 56
    Philippe Halfon, Marc Bourliere, Denis Ouzan, Yaakov Maor, Christophe Renou, Claire Wartelle, Guillaume Pénaranda, Albert Tran, Danielle Botta, Valérie Oules, Paul Castellani, Isabelle Portal, Laurent Argiro, Alain Dessein, A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus, European Journal of Gastroenterology & Hepatology, 2011, 23, 10, 931

    CrossRef

  57. 57
    Femke A.E. Lambers, Maria Prins, Xiomara Thomas, Richard Molenkamp, David Kwa, Kees Brinkman, Jan T.M. van der Meer, Janke Schinkel, Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM, AIDS, 2011, 25, 17, F21

    CrossRef

  58. 58
    Paul J Pockros, Drugs in development for chronic hepatitis C: a promising future, Expert Opinion on Biological Therapy, 2011, 11, 12, 1611

    CrossRef

  59. 59
    Paul J. Pockros, Drugs in Development for Viral Hepatitis, Drugs, 2011, 71, 3, 263

    CrossRef

  60. 60
    Julia di Iulio, Angela Ciuffi, Karen Fitzmaurice, Dermot Kelleher, Margalida Rotger, Jacques Fellay, Raquel Martinez, Sara Pulit, Hansjakob Furrer, Huldrych F. Günthard, Manuel Battegay, Enos Bernasconi, Patrick Schmid, Bernard Hirschel, Eleanor Barnes, Paul Klenerman, Amalio Telenti, Andri Rauch, Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance, Hepatology, 2011, 53, 5
  61. 61
    Christoph Boesecke, Martin Vogel, HIV and hepatitis C co-infection, Current Opinion in HIV and AIDS, 2011, 6, 6, 459

    CrossRef

  62. 62
    Christian M. Lange, Stefan Zeuzem, IL28B single nucleotide polymorphisms in the treatment of hepatitis C, Journal of Hepatology, 2011, 55, 3, 692

    CrossRef

  63. 63
    Jacinta A Holmes, William Sievert, Alexander J Thompson, IL28Bpolymorphism and genetic biomarkers of viral clearance in hepatitis C virus infection, Biomarkers in Medicine, 2011, 5, 4, 461

    CrossRef

  64. 64
    Christian M. Lange, Darius Moradpour, Alexandra Doehring, Hans-Anton Lehr, Beat Müllhaupt, Stephanie Bibert, Pierre-Yves Bochud, Anca T. Antonino, Manuel Pascual, Harald Farnik, Ying Shi, Wolf Otto Bechstein, Christian Moench, Martin-Leo Hansmann, Christoph Sarrazin, Jörn Lötsch, Stefan Zeuzem, Wolf-Peter Hofmann, Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection, Journal of Hepatology, 2011, 55, 2, 322

    CrossRef

  65. 65
    Col Pankaj Puri, Interleukin 28B Polymorphisms and Hepatitis C—Translating the Association into Clinical Decision Making, Journal of Clinical and Experimental Hepatology, 2011, 1, 1, 27

    CrossRef

  66. 66
    Geoffrey W. McCaughan, Nicholas A. Shackel, David G. Bowen, Liver transplantation and hepatitis C: Will understanding the interleukin-28B polymorphisms improve outcomes?, Liver Transplantation, 2011, 17, 3
  67. 67
    Jacinta A. Holmes, Paul V. Desmond, Alexander J. Thompson, Redefining Baseline Demographics: The Role of Genetic Testing in Hepatitis C Virus Infection, Clinics in Liver Disease, 2011, 15, 3, 497

    CrossRef

  68. 68
    Jörn Lötsch, Wolf Peter Hofmann, Christina Schlecker, Stefan Zeuzem, Gerd Geisslinger, Alfred Ultsch, Alexandra Doehring, Single and combinedIL28B,ITPAandSLC28A3host genetic markers modulating response to anti-hepatitis C therapy, Pharmacogenomics, 2011, 12, 12, 1729

    CrossRef

  69. 69
    Ioan Sporea, Alina Popescu, Manuela Curescu, Roxana Sirli, Isabel Dan, Adrian Goldis, Oana Gradinaru, Melania Ardelean, Mirela Danila, Simona Bota, Alexandra Deleanu, The Correlation of Il28B Genotype With Sustained Virologic Response In Romanian patients With Chronic Hepatitis C, Hepatitis Monthly, 2011, 11, 12, 975

    CrossRef

  70. 70
    Brian L. Pearlman, The IL-28 Genotype: How It Will Affect the Care of Patients with Hepatitis C Virus Infection, Current Gastroenterology Reports, 2011, 13, 1, 78

    CrossRef

  71. 71
    T. Motomura, A. Taketomi, T. Fukuhara, Y. Mano, K. Takeishi, T. Toshima, N. Harada, H. Uchiyama, T. Yoshizumi, Y. Soejima, K. Shirabe, Y. Matsuura, Y. Maehara, The Impact of IL28B Genetic Variants on Recurrent Hepatitis C in Liver Transplantation: Significant Lessons from a Dual Graft Case, American Journal of Transplantation, 2011, 11, 6
  72. 72
    Jason Grebely, Gail V. Matthews, Gregory J. Dore, Treatment of acute HCV infection, Nature Reviews Gastroenterology & Hepatology, 2011,

    CrossRef

  73. 73
    Christoph Boesecke, Jürgen K Rockstroh, Treatment of acute hepatitis C infection in HIV-infected patients, Current Opinion in HIV and AIDS, 2011, 6, 4, 278

    CrossRef

  74. 74
    Femke AE Lambers, Kees Brinkman, Janke Schinkel, Ingrid JB Spijkerman, Richard Molenkamp, Roel A Coutinho, Maria Prins, Jan TM van der Meer, Treatment of acute hepatitis C virus infection in HIV-infected MSM: the effect of treatment duration, AIDS, 2011, 25, 10, 1333

    CrossRef

  75. 75
    Ashwin Balagopal, David L. Thomas, Chloe L. Thio, IL28B and the Control of Hepatitis C Virus Infection, Gastroenterology, 2010, 139, 6, 1865

    CrossRef

  76. 76
    Heiner Wedemeyer, Antivirals in Acute Hepatitis C,